Clinical Trials in Ohio

Showing 20661-20680 of 20,938 trials

Study to Evaluate MEDI-534 in Healthy Adults

NCT00111878

The primary objective of this study is to describe the safety and tolerability of a single dose of MEDI-534 when administered to healthy adult volunteers.

Respiratory Syncytial Virus InfectionsParainfluenza Infections

MedImmune LLC120 participantsStarted Apr 2005

Columbus, Ohio, United States • Pittsburgh, Pennsylvania, United States • Dallas, Texas, United States

COMPLETEDPhase 432 miles

Evaluation of Continuous Symptom Treatment of ADHD

NCT00486122

The purpose of this study is to test the hypothesis that atomoxetine administered orally, once a day, at doses up to 1.4 mg/kg/day for approximately 6 weeks given in the morning is superior to placebo in children with ADHD.

Attention Deficit Hyperactivity Disorder

Eli Lilly and Company282 participantsStarted Sep 2003

Columbus, Ohio, United States

TERMINATEDPhase 352 miles

Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy

NCT00243204

This Phase 3 study will compare the efficacy of talabostat plus docetaxel to docetaxel plus placebo in patients with Stage IIIB/IV NSCLC who have failed a platinum-based chemotherapy regimen.

Carcinoma, Non-Small Cell Lung

Point Therapeutics400 participantsStarted Jan 2006

Huntsville, Alabama, United States • Muscle Shoals, Alabama, United States • Anchorage, Alaska, United States +93 more locations

Study to Evaluate MEDI-534 in Healthy Adults

Evaluation of Continuous Symptom Treatment of ADHD

Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy

Find Trials by Condition in Ohio

A Study for the Treatment of Mania Associated With Bipolar I Disorder in Children and Adolescents

CORE: A Study of OPC-6535 With Asacol® in Maintaining Ulcerative Colitis (UC) Remission

Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy

Study of Antiepileptic Drug Effects on Child Development

A Trial Study of SGN-00101 in Treating Pediatric Patients With Recurrent Respiratory Papillomatosis

Comparison of Two Growth Hormone Dosing Methods in Adults With Growth Hormone Deficiency

The Effects of the MME Procedure on Chronic Low Back Pain

DTaP and Apnea/Bradycardia in Preterm Infants

Olanzapine Versus Placebo in the Treatment of Adolescents With Schizophrenia

Efficacy and Safety of Summers Non-Pesticide Lice Asphyxiator (L.A.)for the Treatment of Head Lice

Placebo-Controlled Study of Atomoxetine Hydrochloride in the Treatment of Adults With ADHD and Comorbid Social Anxiety Disorder

A Twelve-Week Study of Varenicline for Safety and Efficacy in Comparison With Placebo and Zyban for Smoking Cessation

12 Week Evaluation of the Safety and Efficacy of a Flexible Dose of CP-526,555 and Placebo for Smoking Cessation

Phase 2 Study of the Safety and Efficacy of UK-500,001 in Adult Patients With COPD

Study Comparing Racivir and Lamivudine in Treatment-Experienced HIV Subjects

Study to Evaluate MEDI-507 in Patients With CD2-Positive Lymphoma/Leukemia

Study Of Combined VISUDYNE Therapy With Kenalog In CNV Secondary To Age-Related Macular Degeneration